Tuberculosis
Apr 28, 2025
Article and Study Summary: Article: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis Published in: N Engl J Med. 2025;392(5):468–482. https://www.nejm.org/doi/full/10.1056/NEJMoa2400327 Authors: Guglielmetti L, Khan U, Velásquez GE, et...
Feb 23, 2023
Article and Study Summary: A 24-week, All-Oral Regimen for Rifampin-Resistant Tuberculosis Published in: N Engl J Med. 2022;387(25):2331-2343. https://www.nejm.org/doi/full/10.1056/NEJMoa2117166 Authors: Nyang’wa B, Berry C, Kazounis E, et al. Summary This...
Jan 12, 2023
Authors: D P Baloyi, M G Anthony, K A Meyerson, S Mazibuko, D Wademan,  L Viljoen, H Myburgh, K du Preez, M Osman, Y Hirsch-Moverman, S Charalambous, H Hausler, A C Hesseling, G Hoddinott Abstract: Background: South Africa has one the highest TB and HIV burdens...
Jul 26, 2022
Abstract: BACKGROUND:Â Child contact management (CCM) is a recognized strategy to prevent TB; however, implementation is suboptimal. PREVENT was a cluster-randomized trial that evaluated the effectiveness and acceptability of a community-based intervention (CBI) to...
Mar 30, 2022
Article and Study Summary: Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children Published in: New England Journal of Medicine 2022;386(10):911-922. https://www.nejm.org/doi/full/10.1056/NEJMoa2104535 Authors: Turkova A, Wills GH, Wobudeya E, et...
